UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
295.57
-1.10 (-0.37%)
At close: May 23, 2025, 4:00 PM
294.74
-0.83 (-0.28%)
After-hours: May 23, 2025, 7:59 PM EDT
UnitedHealth Group Market Cap
UnitedHealth Group has a market cap or net worth of $268.12 billion as of May 23, 2025. Its market cap has decreased by -42.21% in one year.
Market Cap
268.12B
Enterprise Value
318.68B
1-Year Change
-42.21%
Ranking
Category
Stock Price
$295.57
Market Cap Chart
Since December 1, 1998, UnitedHealth Group's market cap has increased from $8.37B to $268.12B, an increase of 3,103.92%. That is a compound annual growth rate of 13.98%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 23, 2025 | 268.12B | -42.41% |
Dec 31, 2024 | 465.54B | -4.40% |
Dec 29, 2023 | 486.95B | -1.70% |
Dec 30, 2022 | 495.37B | 4.74% |
Dec 31, 2021 | 472.94B | 42.14% |
Dec 31, 2020 | 332.73B | 19.46% |
Dec 31, 2019 | 278.52B | 16.21% |
Dec 31, 2018 | 239.66B | 12.18% |
Dec 29, 2017 | 213.64B | 40.25% |
Dec 30, 2016 | 152.33B | 35.86% |
Dec 31, 2015 | 112.12B | 15.56% |
Dec 31, 2014 | 97.03B | 27.99% |
Dec 31, 2013 | 75.81B | 35.34% |
Dec 31, 2012 | 56.01B | 3.68% |
Dec 30, 2011 | 54.03B | 36.02% |
Dec 31, 2010 | 39.72B | 12.14% |
Dec 31, 2009 | 35.42B | 10.24% |
Dec 31, 2008 | 32.13B | -57.28% |
Dec 31, 2007 | 75.20B | 3.91% |
Dec 29, 2006 | 72.37B | -8.08% |
Dec 30, 2005 | 78.74B | 36.85% |
Dec 31, 2004 | 57.54B | 68.58% |
Dec 31, 2003 | 34.13B | 34.26% |
Dec 31, 2002 | 25.42B | 15.22% |
Dec 31, 2001 | 22.06B | 12.74% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 640.72B |
Johnson & Johnson | 367.98B |
AbbVie | 323.71B |
Novo Nordisk | 298.78B |
Abbott Laboratories | 228.44B |
Novartis AG | 221.01B |
AstraZeneca | 218.42B |
Merck & Co. | 194.81B |